E-Cigarette Use Among Adults With CVD Increased During COVID-19 After Years of Decline
August 17th 2023The decrease in e-cigarette use between 2014 and 2019 may be linked to improved education on the harms of the devices, while the increase in 2019 could be attributed to worsened psychological burden during the COVID-19 pandemic.
Read More
Standardizing Digital Health Interventions for Depression May Improve Patient Adherence, Study Finds
August 16th 2023Standardized reporting of patient adherence and engagement among digital health interventions for depression offers more effective comparisons between digital health tools and populations.
Read More
The platinum drugs most effective in treating ovarian cancer are in limited supply due to the drug shortage; the government proposes a plan to prevent hospitals from redistributing Medicaid money; physicians ask for help in treating the high number of children with mental illness coming to the emergency department.
Read More
Race Not Independently Associated With Biologic Access for Psoriasis in the United States
August 16th 2023No significant differences regarding racial backgrounds were found when measuring access to biologics among adult patients with psoriasis living in the United States, according to one study.
Read More
Amazon’s online pharmacy aims to improve access and price transparency for insulin; cases of the COVID-19 Eris variant are increasing globally; the Department of Justice (DOJ) responds to pushbacks of Medicare's drug price negotiation program from the Chamber of Commerce (COC).
Read More
Most US Infants With RSV Were Healthy, Born at Term, Study Finds
August 15th 2023A recent study found that most infants who required intensive care for respiratory syncytial virus (RSV) were healthy and born at term, indicating that preventive interventions for RSV must target all infants, according to the authors.
Read More
Theory-Based Smoking Cessation Interventions Positively Affect Patients With COPD Who Smoke
August 14th 2023Theory-based smoking cessation interventions helped to motivate patients with chronic obstructive pulmonary disease (COPD) who smoke to quit, ultimately improving their quality of life and lung function.
Read More
FDA Approves Elranatamab for Relapsed or Refractory Multiple Myeloma
August 14th 2023The FDA has granted accelerated approval to elranatamab-bcmm (Elrexfio) for the treatment of adult patients with relapsed or refractory multiple myeloma who have previously received at least 4 lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.
Read More